High altitude pulmonary edema. An experiment of Nature to study the underlying mechanisms of hypoxic pulmonary hypertension and pulmonary edema in humans;Edema Pulmonar de Altura Modelo de Estudio de la Fisiopatologia del Edema Pulmonar y de la Hipertension Pulmonar Hipoxica en Humanos

Medicina (Argentina)

Volumn 67, Issue 1, 2007, Pages 71-81

  Schwab, Marcos ^a   Jayet, Pierre Yves ^a   Allemann, Yves ^b   Sartori, Claudio ^a   Scherrer, Urs ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Endothelial dysfunction; Exhaled nitric oxide; High altitude pulmonary edema; Pulmonary hypertension; Sympathetic nervous system; Transepithelial respiratory sodium transport

Indexed keywords

EPITHELIAL SODIUM CHANNEL; NITRIC OXIDE; SODIUM; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ALTITUDE DISEASE; BIOAVAILABILITY; BIOSYNTHESIS; BLOOD PRESSURE; DRUG EFFECT; HUMAN; LUNG ALVEOLUS; LUNG CIRCULATION; LUNG EDEMA; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY HYPERTENSION; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ALTITUDE SICKNESS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; BLOOD PRESSURE; EPITHELIAL SODIUM CHANNEL; HUMANS; HYPERTENSION, PULMONARY; NITRIC OXIDE; PULMONARY ALVEOLI; PULMONARY CIRCULATION; PULMONARY EDEMA; SODIUM; SYMPATHETIC NERVOUS SYSTEM;

EID: 35148833523     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Acosta de J. Historia natural y moral de las Indias. Sevilla, 1590.
2. Ravenhill T. Some experiences of mountain sickness in the Andes. J Trp Med Hyg 1913; 20: 313-20.
3. Hurtado A. Aspectos físicos y patológicos de la vida en las alturas. Lima: Imprenta Rímac 1937.
4. Hurtado A. Respiratory adaptation in the Indian natives of the Peruvian Andes: studies at high altitude. Am J Phys Anthropol 1932; 17: 137-65.
5. Mori-Chaves P. Contribución al estudio del soroche experimental. Manifestaciones pulmonares en el soroche agudo. Anal Fac Med (Lima) 1935: 126-72.
6. Bardalez AV. Algunos casos de edema pulmonar agudo por soroche grave. Anal Fac Med (Lima) 1955; 33: 232-43.
7. Houston C. Acute pulmonary edema of high altitude. N Engl J Med 1960; 263: 478-80.
8. Antezana G, Leguía G, Morales GA, Coudet J, Spielvogel H. Hemodinamic study of high-altitude pulmonary edema (12,200 ft). In: W. Brendel and R.A. Zink (eds.). Topics in Environmental Physiology and Medicine, High altitude physiology and medicine. New York, NY: Springler-Verlag, 1982: 232-42.
9. Hultgren HN, Lopez CE, Lundberg E, Miller H. Physiologic studies of pulmonary edema at high altitude. Circulation 1964; 29: 393-408.
10. Marticorena E, Tapia FA, Dyer J, et al. Pulmonary edema by ascending to high altitudes. J Dis Chest 1964; 45: 273-83.
11. Peñaloza D, Sime F. Circulatory dynamics during high altitude pulmonary edema. Am J Cardiol 1969; 23: 369-78.
12. Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001; 345: 107-14.
13. Hultgren HN. High-altitude pulmonary edema: current concepts. Ann Rev Med 1996; 47: 267-84.
14. Scherrer U, Vollenweider L, Delabays A, et al. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med 1996; 334: 624-9.
15. Hackett PH, Roach RC. High altitude pulmonary edema. J Wilderness Med 1990; 1: 3-26.
16. Vock P, Fretz C, Franciolli M, Bärtsch P. High-altitude pulmonary edema: findings at high-altitude chest radiography and physical examination. Radiology 1989; 170: 661-6.
17. Lobenhoffer HP, Zink RA, Brendel W. High altitude pulmonary edema: analysis of 166 cases. In: W. Brendel and R.A. Zink (eds.). Topics in Environmental Physiology and Medicine, High altitude physiology and medicine. New York, NY: Springler-Verlag, 1982: 219-31.
18. Cremona G, Asnaghi R, Baderna P, et al. Pulmonary extravascular fluid accumulation in recreational climbers: a prospective study. Lancet 2002; 359: 303-9.
19. Bärtsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med 1991; 325: 1284-9.
20. Hultgren HN, Marticorena EA. High altitude pulmonary edema: epidemiologic observations in Peru. Chest 1978; 74: 372-6.
21. Schoene RB. Pulmonary edema at high altitude: review, pathophysiology, and update. Clin Chest Med 1985; 6: 491-507.
22. Staub NC. Pulmonary edema-hypoxia and overperfusion. N Engl J Med 1980; 302: 1085-7.
23. Scherrer U, Sartori C, Lepori M, et al. High-altitude pulmonary edema: from exaggerated pulmonary hypertension to a defect in transepithelial sodium transport. Adv Exp Med Biol 1999; 474: 93-107.
24. Hackett PH, Creagh CE, Grover RF, Hinigman B, Houston CS. High altitude pulmonary edema in persons without the right pulmonary artery. N Engl J Med 1980; 302: 1070-3.
25. Rios B, Driscoll D, McNamara DG. High altitude pulmonary edema with absent pulmonary artery. Pediatrics 1985; 75: 314-7.
26. Torrington KG. Recurrent high-altitude illness associated with right pulmonary artery occlusion from granulomatous mediastinitis. Chest 1989; 96: 1422-3.
27. Durmowicz AG. Pulmonary edema in 6 children with Down syndrome during travel to moderate altitudes. Pediatrics 2001; 108: 443-7.
28. Oelz O, Maggiorini M, Ritter M, et al. Nifedipine for high altitude pulmonary oedema. Lancet 1989; 2: 1241-4.
29. Hackett PH, Roach RC, Hartig GS, Green ER, Levine BD. The effect of vasodilatators on pulmonary hemodynamics in high-altitude pulmonary edema-a comparison. Int J Sports Med 1992; 13: 68-74.
30. Maggiorini M, Melot C, Pierre S, et al. High-Altitude Pulmonary Edema Is Initially Caused by an Increase in Capillary Pressure. Circulation 2001; 103: 2078-83.
31. Bartsch P, Maggiorini M, Mairbaurl H, Vock P, Swenson ER. Pulmonary extravascular fluid accumulation in climbers. Lancet 2002; 360: 571; author reply 571-2.
32. Blitzer ML, Loh E, Roddy MA, Stamler JS, Creager MA. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J Am Coll Cardiol 1996; 28: 591-6.
33. Ahsan A, Charu R, Pasha MA, Norboo T, Afrin F, Baig MA. eNOS allelic variants at the same locus associate with HAPE and adaptation. Thorax 2004; 59: 1000-2.
34. Droma Y, Hanaoka M, Ota M, et al. Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation 2002; 106: 826-30.
35. Ahsan A, Norboo T, Baig MA, Qadar Pasha MA. Simultaneous selection of the wild-type genotypes of the G894T and 4B/ 4A polymorphisms of NOS3 associate with high-altitude adaptation. Ann Hum Genet 2005; 69: 260-7.
36. Bowers R, Cool C, Murphy RC, et al. Oxidative stress in severe pulmonary hypertension. Am J Respir Crit Care Med 2004; 169: 764-9.
37. Hoshikawa Y, Ono S, Suzuki S, et al. Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. J Appl Physiol 2001; 90: 1299-306.
38. Irodova NL, Lankin VZ, Konovalova GK, Kochetov AG, Chazova IE. Oxidative stress in patients with primary pulmonary hypertension. Bull Exp Biol Med 2002; 133: 580-2.
39. Sartori C, Lepori M, Busch T, et al. Exhaled nitric oxide does not provide a marker of vascular endothelial function in healthy humans. Am J Respir Crit Care Med 1999; 160: 879-82.
40. Busch T, Bartsch P, Pappert D, et al. Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to highaltitude pulmonary edema. Am J Respir Crit Care Med 2001; 163: 368-73.
41. Duplain H, Sartori C, Lepori M, et al. Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation. Am J Respir Crit Care Med 2000; 162: 221-4.
42. Goerre S, Wenk M, Bärtsch P, et al. Endothelin-1 in pulmonary hypertension associated with high altitude exposure. Circulation 1995; 91: 359-64.
43. Sartori C, Vollenweider L, Loffler BM, et al. Exaggerated endothelin release in high-altitude pulmonary edema. Circulation 1999; 99: 2665-8.
44. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993; 92: 99-104.
45. Krasney JA. A neurogenic basis for acute altitude illness. Med Sci Sports Exerc 1994; 26: 195-208.
46. Duplain H, Vollenweider L, Delabays A, Nicod P, Bärtsch P, Scherrer U. Augmented sympathetic activation during short-term hypoxia and high-altitude exposure in subjects susceptible to high altitude pulmonary edema. Circulation 1999; 99: 1713-8.
47. Owlya R, Vollenweider L, Trueb L, et al. Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during exercise in humans. Circulation 1997; 96: 3897-903.
48. Sartori C, Lepori M, Scherrer U. Interaction between nitric oxide and the cholinergic and sympathetic nervous system in cardiovascular control in humans. Pharmacol Ther 2005; 106: 209-20.
49. Barker DJP. Mothers, babies, and disease in later life. London: BMJ Books, 1994.
50. Morin FC, Stenmark KR. Persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 1995; 151: 2010-32.
51. Hakim TS, Mortola JP. Pulmonary vascular resistance in adult rats exposed to hypoxia in the neonatal period. Can J Physiol Pharmacol 1990; 68: 419-24.
52. Sartori C, Allemann Y, Trueb L, Delabays A, Nicod P, Scherrer U. Augmented vasoreactivity in adult life associated with perinatal vascular insult. Lancet 1999; 353: 2205-7.
53. Smith APL, Emery CJ, Higenbottam TW. Perinatal chronic hypoxia decreases endothelial nitric oxide synthase (NOS III) and increases preproendothelin-1 (ppET-1) mRNA levels in rat. Eur Respir J 1997; 10 (Suppl 25): 433s.
54. Sartori C, Allemann Y, Trueb L, et al. Exaggerated pulmonary hypertension is not sufficient to trigger highaltitude pulmonary oedema in humans. Schweiz Med Wochenschr 2000; 130: 385-9.
55. Egli M, Duplain H, Lepori M, et al. Defective respiratory amiloride-sensitive sodium transport predisposes to pulmonary oedema and delays its resolution in mice. J Physiol 2004; 560: 857-65.
56. Sartori C, Allemann Y, Duplain H, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002; 346: 1631-6.
57. Sartori C, Matthay MA, Scherrer U. Transepithelial sodium and water transport in the lung. Major player and novel therapeutic target in pulmonary edema. Adv Exp Med Biol 2001; 502: 315-38.
58. Hummler E, Barker P, Gatzy J, et al. Early death due to defective neonatal lung liquid clearance in aENaCdeficient mice. Nature Genet 1996; 12: 325-8.
59. Sartori C, Duplain H, Lepori M, et al. High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects. Eur Respir J 2004; 23: 916-20.
60. Berthiaume Y, Staub NC, Matthay MA. Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J Clin Invest 1987; 79: 335-43.
61. Jayet PY, Thalmann S, Stuber T, et al. Offspring of preeclamptic mother are predisposed to hypoxic pulmonary hypertension. FASEB J 2005; 19: A1330.
62. Beall CM, Laskowski D, Strohl KP, et al. Pulmonary nitric oxide in mountain dwellers. Nature 2001; 414: 411-2.
63. Richalet JP, Gratadour P, Robach P, et al. Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am J Respir Crit Care Med 2005; 171: 275-81.
64. Thalmann S, Allemann Y, Jayet PY, et al. Oxidative stress mediated chronic pulmonary hypertension in reentry pulmonary edema-prone high altitude dwellers. FASEB J 2005; 19: A1333.
65. Sartori C, Trueb L, Allemann Y, Nicod P, Scherrer U. Transient perinatal hypoxic pulmonary hypertension predisposes to exaggerated pulmonary vasoconstriction in young adults exposed to high altitude. FASEB J 1997; 11: A135.